Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Prescription rates for commonly used drugs before and after a prostate cancer diagnosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Incidence of penile intraepithelial neoplasia and incidence and survival of penile cancer in Denmark, 1997 to 2018

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pregnancy-associated cancer and the risk of second primary cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Non-aspirin NSAID use and mortality of endometrial cancer. A nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Endometrial cancer risk after fertility treatment: a population-based cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the Interphone Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prescription rates for commonly used drugs before and after a prostate cancer diagnosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Selective arterial embolization of renal angiomyolipomas: A 10-year experience

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Charlotte Skriver
  • Christian Dehlendorff
  • Michael Borre
  • Klaus Brasso
  • Signe Benzon Larsen
  • Anne Tjønneland
  • Anton Pottegård
  • Jesper Hallas
  • Henrik Toft Sørensen
  • Søren Friis
Vis graf over relationer

PURPOSE: Epidemiologic studies suggest that use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce prostate cancer risk. We examined these associations overall and according to clinical and lifestyle parameters.

METHODS: We identified male participants in the Danish Diet, Cancer and Health Study (n = 26,339), holding information on anthropometric measures and lifestyle factors. From Danish nationwide registries and medical records, we retrieved complete prescription histories and prostate cancer occurrence and characteristics. Cox regression was used to estimate hazard ratios (HRs) for prostate cancer associated with low-dose aspirin or nonaspirin NSAID use, overall and by clinical characteristics, anthropometric measures, and lifestyle factors.

RESULTS: We identified 1,927 prostate cancer cases during a median follow-up of 17.0 years. Low-dose aspirin use was not associated with overall prostate cancer risk, but a reduced HR for nonaggressive prostate cancer (high use [≥ 1,825 tablets]: 0.79; 95% confidence interval (CI) 0.60-1.04) and an increased HR for aggressive disease (high use: 1.27; 95% CI 1.00-1.61) was observed with low-dose aspirin use. Long-term, high-intensity use (≥ 10 years with ≥ 0.25 defined daily doses/day) of nonaspirin NSAIDs was associated with an increased HR for prostate cancer (1.35, 95% CI 0.99-1.84), confined to localized and nonaggressive disease. No consistent variation in HRs was seen in analyses stratified by height, body mass index, smoking, and alcohol use.

CONCLUSION: Low-dose aspirin or other NSAID use was not associated with reduced prostate cancer risk, neither overall nor according to anthropometric measures, smoking, or alcohol use. The variation according to outcome characteristics warrants further investigation.

OriginalsprogEngelsk
TidsskriftCancer causes & control
Vol/bind31
Udgave nummer2
Sider (fra-til)139-151
Antal sider13
ISSN0957-5243
DOI
StatusUdgivet - feb. 2020

ID: 58622777